Bozic Carmen sold VRTX

June 15, 2026 · Form 4 insider transaction

Bozic Carmen sold 4,062 shares of Vertex Pharmaceuticals Incorporated at $450.00 per share, a transaction worth $1.83M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
4,062
Price
$450.00
Total value
$1.83M
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after16,953
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.

View the original Form 4 on SEC EDGAR